Efficacy and Safety of the Selective Progesterone Receptor Modulator (PRM) Vilaprisan - 24-Week Outcomes From Asteroid 2
Fertility and Sterility - Netherlands
doi 10.1016/j.fertnstert.2018.07.189
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2018
Authors
Publisher
Elsevier BV